PuSH - Publication Server of Helmholtz Zentrum München

20 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Jiang, X.* et al.: Shared heritability and functional enrichment across six solid cancers. Nat. Commun. 10:431 (2019)
2.
Day, F.R.* et al.: Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat. Genet. 49, 834-841 (2017)
3.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat. Genet. 47, 1294-1303 (2015)
4.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility, and BRCA1-mediated DNA repair. Obstet. Gynecol. 70, 758-762 (2015)
5.
Khan, S.* et al.: MicroRNA related polymorphisms and breast cancer risk. PLoS ONE 9:e109973 (2014)
6.
Perry, J.R.B.* et al.: Parent-of-origin specific allelic associations among 106 genomic1 loci for age at menarche. Nature 514, 92-97 (2014)
7.
French, J.D.* et al.: Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet. 92, 489-503 (2013)
8.
Garcia-Closas, M.* et al.: Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392-398 (2013)
9.
Hein, R.* et al.: A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: A two-stage design with replication. Breast Cancer Res. Treat. 138, 529-542 (2013)
10.
Michailidou, K.* et al.: Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353-361 (2013)
11.
Ghoussaini, M.* et al.: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 44, 312-319 (2012)
12.
Siddiq, A.* et al.: A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet. 21, 5373-5384 (2012)
13.
Rabstein, S.* et al.: N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer. Eur. J. Cancer Prev. 19, 100-109 (2010)
14.
Justenhoven, C.* et al.: Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors. Int. J. Cancer 124, 2077-2081 (2009)
15.
Justenhoven, C.* et al.: The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 111, 171-177 (2008)
16.
Justenhoven, C.* et al.: Breast cancer: A candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res. Treat. 108, 137-149 (2008)
17.
Jaremko, M.* et al.: Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet. Genomics 17, 529-538 (2007)
18.
Rokavec, M.* et al.: A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk. Clin. Cancer Res. 13, 7506-7514 (2007)
19.
Jaremko, M.* et al.: MALDI-TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum. Mutat. 25, 232-238 (2005)
20.
Justenhoven, C.* et al.: ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol. Biomarkers Prev. 13, 2059-2064 (2004)